Inbar Raber

ORCID: 0000-0003-1282-1001
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Diversity and Career in Medicine
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Blood Pressure and Hypertension Studies
  • Healthcare professionals’ stress and burnout
  • Diabetes Treatment and Management
  • Colorectal Cancer Treatments and Studies
  • Cardiovascular Disease and Adiposity
  • Heart Rate Variability and Autonomic Control
  • Cancer Treatment and Pharmacology
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Healthcare cost, quality, practices
  • Cardiomyopathy and Myosin Studies
  • Skin Protection and Aging
  • Cardiac Arrhythmias and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Health and Disease Prevention
  • Lipoproteins and Cardiovascular Health
  • Heart Failure Treatment and Management
  • Hormonal Regulation and Hypertension
  • Infective Endocarditis Diagnosis and Management

Beth Israel Deaconess Medical Center
2018-2022

Harvard University
2019-2022

Deaconess Hospital
2021

Beth Israel Deaconess Hospital
2020

Hadassah Medical Center
2020

Stanford University
2015-2016

Rosacea is a common, chronic skin disease that currently incurable. Although environmental factors influence rosacea, the genetic basis of rosacea not established. In this genome-wide association study, discovery group 22,952 individuals (2,618 cases and 20,334 controls) was analyzed, leading to identification two significant single-nucleotide polymorphisms (SNPs) associated with one which replicated in new 29,481 (3,205 26,262 controls). The confirmed SNP, rs763035 (P=8.0 × 10(-11) group;...

10.1038/jid.2015.53 article EN cc-by-nc-nd Journal of Investigative Dermatology 2015-02-19

Heart failure with reduced ejection fraction produces substantial morbidity, mortality, and health care costs. Dapagliflozin is the first sodium-glucose cotransporter 2 inhibitor approved for treatment of heart fraction.To examine cost-effectiveness adding dapagliflozin to guideline-directed medical therapy in patients or without diabetes.This economic evaluation developed used a Markov cohort model that compared alone hypothetical US adults similar clinical characteristics as participants...

10.1001/jamanetworkopen.2021.14501 article EN cc-by-nc-nd JAMA Network Open 2021-07-27

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning /...

10.1001/jama.2019.3353 article EN JAMA 2019-04-12

Abstract Background The fluoropyrimidines, 5-fluorouracil (5-FU) and capecitabine, are commonly used chemotherapeutic agents that have been associated with coronary vasospasm. Methods In this retrospective case-control study, we identified patients at our institution who received 5-FU or capecitabine in 2018. We compared characteristics of experienced cardiotoxicity controls. described phenotypes outcomes cardiotoxic cases. Results 177 fluoropyrimidines. After adjudication, 4.5% the cohort...

10.1634/theoncologist.2019-0762 article EN The Oncologist 2019-12-16

Hypertension control has worsened nationally, and treatment intensification is important for control. National trends appropriate blood pressure older adults are unknown. We determine the proportion of ambulatory visits where with hypertension were appropriately intensified on antihypertensives from 2008 to 2018.Data Ambulatory Medical Care Survey used. a nationally representative sample visits. Adults 60 years or included. Appropriate antihypertensive was defined as addition an reading...

10.1161/hypertensionaha.122.19882 article EN Hypertension 2022-10-18

Women cardiologists receive lower salaries than men; however, it is unknown whether US Centers for Medicare & Medicaid Services (CMS) reimbursement also differs by gender and contributes to the salaries.To determine differences exist in reimbursements, charges, per charge from CMS.This cross-sectional analysis used CMS database obtain 2016 data cardiologists. These included reimbursements cardiologists, charges submitted, unique billing codes. Gender evaluation management procedural both...

10.1001/jamacardio.2021.3385 article EN JAMA Cardiology 2021-09-08

While much is known about genes that promote aging, little protect against or prevent particularly in human skin. The main objective of this study was to perform an unbiased, whole transcriptome search for associate with intrinsic skin youthfulness. To accomplish this, healthy women (n = 122) European descent, ages 18-89 years Fitzpatrick type I/II were examined facial aging parameters and clinical covariates, including smoking ultraviolet exposure. Skin youthfulness defined as the top 10%...

10.1371/journal.pone.0165913 article EN cc-by PLoS ONE 2016-11-09

Estimates of an individual's cumulative ultraviolet (UV) radiation exposure can be useful since increases skin cancer risk, but a comprehensive tool that is practical for use in the clinic does not currently exist. The objective this study to develop geographically-adjusted systematically estimate self-reported UV exposure, investigate association these estimates with diagnosis, and assess test reliability.A 12-item online questionnaire from validated survey items was administered volunteers...

10.1186/s12895-016-0038-1 article EN BMC Dermatology 2016-01-20

Introduction: In May 2020, the US FDA approved use of dapagliflozin, an SGLT2 inhibitor, for reduction cardiovascular death and heart failure hospitalization in patients with reduced ejection fraction (HFrEF). We examined cost-effectiveness adding dapagliflozin to guideline-directed medical therapy (GDMT) or without diabetes. Methods: developed a state-transition Markov model inputs from DAPA-HF trial, review documents, published literature, nationally representative datasets (Panel A). The...

10.1161/circ.142.suppl_3.15981 article EN Circulation 2020-11-17
Coming Soon ...